Protara Therapeutics, Inc. Operating Lease Cost
Protara Therapeutics, Inc. (TARA) reported Operating Lease Cost of $338.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-11
- Protara Therapeutics, Inc. operating lease, cost for the quarter ending 2026-06-30 was $338.00K, a 0.00% change year-over-year.
- Protara Therapeutics, Inc. operating lease, cost for the quarter ending 2026-03-31 was $338.00K, a 0.00% change year-over-year.
- Protara Therapeutics, Inc. operating lease, cost for the quarter ending 2025-12-31 was $339.00K, a 0.00% change year-over-year.
- Protara Therapeutics, Inc. operating lease, cost for the quarter ending 2025-09-30 was $338.00K, a 0.00% change year-over-year.
- Protara Therapeutics, Inc. operating lease, cost for fiscal 2025 was $1.35M, a 0.00% change from fiscal 2024.
- Protara Therapeutics, Inc. operating lease, cost for fiscal 2024 was $1.35M, a 4.92% decline from fiscal 2023.
- Protara Therapeutics, Inc. operating lease, cost for fiscal 2023 was $1.42M, a 4.17% increase from fiscal 2022.
- Protara Therapeutics, Inc. operating lease, cost for fiscal 2022 was $1.37M, a 30.10% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 3 month as first filed | Operating Lease, Cost 6 month | Operating Lease, Cost 6 month as first filed | Operating Lease, Cost 9 month | Operating Lease, Cost 9 month as first filed | Operating Lease, Cost 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $338.00K 10-Q · filed 2026-08-11 | $676.00K 10-Q · filed 2026-08-11 | $1.01M derived: sum of 3 quarters · filed 2026-08-11 | $1.35M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2026-03-31 | $338.00K 10-Q · filed 2026-05-13 | $677.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.01M derived: sum of 3 quarters · filed 2026-05-13 | $1.35M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-12-31 | $339.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $677.00K derived: sum of 2 quarters · filed 2026-03-10 | $1.01M derived: sum of 3 quarters · filed 2026-08-11 | $1.35M 10-K · filed 2026-03-10 | |||
| 2025-09-30 | $338.00K 10-Q · filed 2025-11-10 | $676.00K derived: sum of 2 quarters · filed 2026-08-11 | $1.01M 10-Q · filed 2025-11-10 | $1.35M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-06-30 | $338.00K 10-Q · filed 2026-08-11 | $676.00K 10-Q · filed 2026-08-11 | $1.01M derived: sum of 3 quarters · filed 2026-08-11 | $1.35M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-03-31 | $338.00K 10-Q · filed 2026-05-13 | $677.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.01M derived: sum of 3 quarters · filed 2026-05-13 | $1.35M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $339.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $677.00K derived: sum of 2 quarters · filed 2026-03-10 | $1.01M derived: sum of 3 quarters · filed 2026-03-10 | $1.35M 10-K · filed 2026-03-10 | |||
| 2024-09-30 | $338.00K 10-Q · filed 2025-11-10 | $676.00K derived: sum of 2 quarters · filed 2025-11-10 | $1.01M 10-Q · filed 2025-11-10 | $1.41M derived: sum of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | $338.00K 10-Q · filed 2025-08-11 | $676.00K 10-Q · filed 2025-08-11 | $1.07M derived: sum of 3 quarters · filed 2025-08-11 | $1.42M derived: sum of 4 quarters · filed 2025-08-11 | |||
| 2024-03-31 | $338.00K 10-Q · filed 2025-05-08 | $737.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.08M derived: sum of 3 quarters · filed 2025-05-08 | $1.42M derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | $399.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $740.00K derived: sum of 2 quarters · filed 2025-03-05 | $1.08M derived: sum of 3 quarters · filed 2025-03-05 | $1.42M 10-K · filed 2025-03-05 | |||
| 2023-09-30 | $341.00K 10-Q · filed 2024-11-12 | $683.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.02M 10-Q · filed 2024-11-12 | $1.37M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $342.00K 10-Q · filed 2024-08-06 | $683.00K 10-Q · filed 2024-08-06 | $1.02M derived: sum of 3 quarters · filed 2024-08-06 | $1.37M derived: sum of 4 quarters · filed 2024-08-06 | |||
| 2023-03-31 | $341.00K 10-Q · filed 2024-05-02 | $683.00K derived: sum of 2 quarters · filed 2024-05-02 | $1.02M derived: sum of 3 quarters · filed 2024-05-02 | $1.37M derived: sum of 4 quarters · filed 2024-05-02 | |||
| 2022-12-31 | $342.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $684.00K derived: sum of 2 quarters · filed 2024-03-13 | $1.03M derived: sum of 3 quarters · filed 2024-03-13 | $1.37M 10-K · filed 2024-03-13 | |||
| 2022-09-30 | $342.00K 10-Q · filed 2023-11-03 | $684.00K derived: sum of 2 quarters · filed 2023-11-03 | $1.02M 10-Q · filed 2023-11-03 | $1.36M derived: sum of 4 quarters · filed 2023-11-03 | |||
| 2022-06-30 | $342.00K 10-Q · filed 2023-08-03 | $683.00K 10-Q · filed 2023-08-03 | $1.02M derived: sum of 3 quarters · filed 2023-08-03 | $1.39M derived: sum of 4 quarters · filed 2023-08-03 | |||
| 2022-03-31 | $341.00K 10-Q · filed 2023-05-04 | $679.00K derived: sum of 2 quarters · filed 2023-05-04 | $1.05M derived: sum of 3 quarters · filed 2023-05-04 | $1.34M derived: sum of 4 quarters · filed 2023-05-04 | |||
| 2021-12-31 | $338.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $705.00K derived: sum of 2 quarters · filed 2023-03-08 | $995.00K derived: sum of 3 quarters · filed 2023-03-08 | $1.05M 10-K · filed 2023-03-08 | |||
| 2021-09-30 | $367.00K 10-Q · filed 2022-11-03 | $657.00K derived: sum of 2 quarters · filed 2022-11-03 | $712.00K 10-Q · filed 2022-11-03 | $744.00K derived: sum of 4 quarters · filed 2022-11-03 | |||
| 2021-06-30 | $290.00K 10-Q · filed 2022-08-09 | $345.00K 10-Q · filed 2022-08-09 | $377.00K derived: sum of 3 quarters · filed 2022-08-09 | $398.00K derived: sum of 4 quarters · filed 2022-08-09 | |||
| 2021-03-31 | $55.00K 10-Q · filed 2022-05-05 | $87.00K derived: sum of 2 quarters · filed 2022-05-05 | $108.00K derived: sum of 3 quarters · filed 2022-05-05 | $128.00K derived: sum of 4 quarters · filed 2022-05-05 | |||
| 2020-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $53.00K derived: sum of 2 quarters · filed 2022-03-09 | $73.00K derived: sum of 3 quarters · filed 2022-03-09 | $93.00K 10-K · filed 2022-03-09 | |||
| 2020-09-30 | $21.00K 10-Q · filed 2021-11-04 | $21.15K 10-Q · filed 2020-11-12 | $41.00K derived: sum of 2 quarters · filed 2021-11-04 | $61.00K 10-Q · filed 2021-11-04 | $60.64K 10-Q · filed 2020-11-12 | ||
| 2020-06-30 | $20.00K 10-Q · filed 2021-08-05 | $19.75K 10-Q · filed 2020-07-31 | $39.00K 10-Q · filed 2021-08-05 | $39.49K 10-Q · filed 2020-07-31 | |||
| 2020-03-31 | $20.00K 10-Q · filed 2021-05-06 | $19.75K 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |